EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies

Geraldine M Gillespie iD, Max N Quastel, Andrew J McMichael

Immunological Reviews · 2025-01 · 329 (1)

DOI: 10.1111/imr.13434 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 03.01.2025. Verfasst von Geraldine M Gillespie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Center for Immuno-Oncology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, HLA-E Antigens, Killer Cells, Natural, Protein Binding. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health (USA), Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HLA‐E is a nonclassical, nonpolymorphic, class Ib HLA molecule. Its primary function is to present a conserved nonamer peptide, termed VL9, derived from the signal sequence of classical MHC molecules to the NKG2x‐CD94 receptors on NK cells and a subset of T lymphocytes. These receptors regulate the function of NK cells, and the importance of this role, which is conserved across mammalian species, probably accounts for the lack of genetic polymorphism. A second minor function is to present other, weaker binding, pathogen‐derived peptides to T lymphocytes. Most of these peptides bind suboptimally to HLA‐E, but this binding appears to be enabled by the relative stability of peptide‐free, but receptive, HLA‐E‐β2m complexes. This, in turn, may favor nonclassical antigen processing that may be associated with bacteria infected cells. This review explores how the structure of HLA‐E, bound to different peptides and then to NKG2‐CD94 or T‐cell receptors, relates to HLA‐E cell biology and immunology. A detailed understanding of this molecule could open up opportunities for development of universal T‐cell and NK‐cell‐based immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histocompatibility Antigens Class IHLA-E AntigensKiller Cells, NaturalProtein BindingAntigen PresentationHumansAnimalsT-LymphocytesReceptors, ImmunologicNK Cell Lectin-Like Receptor Subfamily CStructure-Activity RelationshipPeptidesNK Cell Lectin-Like Receptor Subfamily DReceptors, Antigen, T-CellProtein Conformation

Stichwörter der Autor:innen

CD8 T cellsHLA‐EMHC class IMHC‐ENKG2AT‐cell receptors

Substanzen

Histocompatibility Antigens Class IHLA-E AntigensReceptors, ImmunologicNK Cell Lectin-Like Receptor Subfamily CPeptidesNK Cell Lectin-Like Receptor Subfamily DReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Nuffield Department of Medicine, Center for Immuno-Oncology, University of Oxford, Oxford, UK.

ORCID-Profile: Geraldine M Gillespie

Förderung

  • NIAID NIH HHS
  • National Institute of Health (USA)
  • Bill and Melinda Gates Foundation
  • Wellcome Trust

Zitieren

APA

Gillespie, G. M., Quastel, M. N., & McMichael, A. J. (2025). HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies. Immunological Reviews, 329(1). https://doi.org/10.1111/imr.13434

Vancouver

Gillespie GM, Quastel MN, McMichael AJ. HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies. Immunological Reviews. 2025;329(1). doi:10.1111/imr.13434

BibTeX
@article{Gillespie2025,
  author = {Gillespie, Geraldine M and Quastel, Max N and McMichael, Andrew J},
  title = {HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies},
  journal = {Immunological Reviews},
  year = {2025},
  volume = {329},
  number = {1},
  doi = {10.1111/imr.13434}
}
Kostenlos starten →